Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"
Mexico City, 14000, Mexico
NCT Number: NCT01872793
Despite the importance of nutritional status in patient's outcome, there is no gold standard for nutritional assessment. Traditional techniques used in healthy subjects to assess nutritional status cannot be used in cirrhotic patients due especially to ascites and peripheral edema, and altered rates of biochemical markers due to liver failure.
Bioelectrical impedance vector analysis has emerged as a useful method to assess body composition and nutritional status especially in patients at the extremes of body weight (fluid overload, excess of adipose tissue, etc.).
With previous results from our research group, BIVA showed to be useful for evaluating cirrhotic patients.
The aim of this study is to validate our previous results and validate BIVA for nutritional assessment in patients with liver cirrhosis
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Mexico City, 14000, Mexico
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Diagnose of liver cirrhosis by two or more of the following criteria:
Exclusion criteria
Time frame: At the time of inclusion, every six months up to 36 months
It will be assessed by bioelectrical impedance vector analysis
Time frame: Through study completion, an average of 36 months.
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Other
Validation of Bioelectrical Impedance Vector Analysis for Nutritional Assessment in Patients With Cirrhosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07561138
Atrophy, Behavior
Athens, Attica, Greece
View Trial DetailsNCT05513651
Digestive System Diseases, Fibrosis
Xi'an, Shannxi, China
View Trial DetailsNCT04113317
Digestive System Diseases, Fibrosis
Jakarta, Java, Indonesia
View Trial DetailsNCT07701031
Digestive System Diseases, Fibrosis
Münster, Germany
View Trial Details